Mitochondria act as a key regulatory factor in cancer progression: Current concepts on mutations, mitochondrial...

Area of Science:

• Biochemistry
• Oncology
• Genetics

Background:

• Mitochondria are vital for cellular homeostasis, but their dysfunction, particularly due to mitochondrial DNA (mtDNA) alterations, disrupts cellular balance and contributes to disease.
• Mitochondrial imbalances can initiate genetic mutations, promoting tumorigenesis, cancer progression, and survival.

Purpose of the Study:

• To comprehensively review epigenetic and genetic alterations affecting mitochondrial function in cancer.
• To explore the roles of cellular metabolism, ethnicity, mitochondrial dynamics, miRNAs, and exosomes in cancer promotion.
• To summarize current therapeutic strategies targeting mitochondria for anti-cancer treatment.

Main Methods:

• Literature review of epigenetic and genetic alterations impacting mitochondrial function.
• Analysis of factors influencing mitochondrial function, including cellular metabolism and ethnicity.
• Review of recent insights into mitochondrial dynamics, miRNAs, exosomes, and immune cell interactions.
• Summary of emerging therapeutic approaches targeting mitochondria in cancer treatment.

Main Results:

• Mitochondrial dysfunction is implicated in numerous diseases, notably cancer, through genetic and epigenetic modifications.
• Alterations in mitochondrial dynamics, miRNAs, and exosomes play significant roles in cancer promotion and immune evasion.
• Ethnicity can influence the impact of mitochondrial dysfunction on cancer.

Conclusions:

• Mitochondrial dysfunction is a critical factor in cancer initiation and progression.
• Understanding mitochondrial alterations provides avenues for novel anti-cancer therapies.
• Targeting mitochondria represents a promising frontier in cancer treatment strategies.